Page last updated: 2024-09-03

n-benzyloxycarbonylprolylprolinal and Neoplasms

n-benzyloxycarbonylprolylprolinal has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dufresne, C; Hédou, D; Labarre, A; Mittermaier, A; Moitessier, N; Plescia, J; Pousse, ME1

Other Studies

1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and Neoplasms

ArticleYear
Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    European journal of medicinal chemistry, 2022, Oct-05, Volume: 240

    Topics: Endopeptidases; Enzyme Inhibitors; Humans; Membrane Proteins; Neoplasms; Prolyl Oligopeptidases; Serine Endopeptidases

2022